Compare WDFC & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WDFC | TXG |
|---|---|---|
| Founded | 1953 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.8B |
| IPO Year | 1995 | 2019 |
| Metric | WDFC | TXG |
|---|---|---|
| Price | $236.31 | $20.64 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 14 |
| Target Price | ★ $300.00 | $17.18 |
| AVG Volume (30 Days) | 128.6K | ★ 2.6M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 1.73% | N/A |
| EPS Growth | 30.92 | ★ 76.97 |
| EPS | ★ 1.28 | N/A |
| Revenue | ★ $488,109,000.00 | $245,893,000.00 |
| Revenue This Year | $7.14 | N/A |
| Revenue Next Year | $6.02 | $7.32 |
| P/E Ratio | $184.83 | ★ N/A |
| Revenue Growth | 19.49 | ★ 68.06 |
| 52 Week Low | $175.38 | $6.78 |
| 52 Week High | $253.48 | $23.56 |
| Indicator | WDFC | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 51.18 | 51.47 |
| Support Level | $235.36 | $11.62 |
| Resistance Level | $237.33 | $23.56 |
| Average True Range (ATR) | 7.40 | 1.29 |
| MACD | -1.85 | 0.18 |
| Stochastic Oscillator | 25.54 | 50.90 |
WD-40 Co is a global marketing organization focused on developing and selling products that solve maintenance and cleaning problems internationally. It offers two product groups: maintenance products, including the flagship WD-40 Multi-Use Product, which serves as a lubricant, rust preventative, penetrant, and moisture displacer, marketed globally; and homecare and cleaning products, mainly sold in North America, the UK, and Australia. The company distributes its products through hardware stores, automotive parts outlets, industrial suppliers, mass retailers, online platforms, and specialty retailers across the Americas, EIMEA, and Asia-Pacific, with the majority of revenue generated in the Americas.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).